Novartis India says will continue to file for patents | business | Hindustan Times
Today in New Delhi, India
Jan 18, 2017-Wednesday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Novartis India says will continue to file for patents

business Updated: Apr 01, 2013 15:23 IST

Reuters
Highlight Story

Novartis India Ltd, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the the Supreme Court rejected its plea for patent protection of its drug Glivec.

Novartis India will also continue to invest there, but with caution, Ranjit Shahani, who is also the managing director of the company, told reporters after the Supreme Court judgment.

Earlier on Monday, the court dismissed Novartis' petition seeking patent protection for cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.

<